CD8A and neoplasm: To confirm that the CD8+ T cell subsets emerging in RT+CTLA4i treated mice were detectable consistently in the tumor of individual mice, cluster-specific gene signatures were constructed and used to interrogate the bulk RNA sequencing data by calculating log2 fold-change weighted enrichment scores based on each gene signature.